Omics! Omics!

A computational biologist's personal views on new technologies & publications on genomics & proteomics and their impact on drug discovery

Sunday, May 29, 2016

London Calling: Notes on Brownian Commotion

›
I'm behind on writing up London Calling.  I can partly blame a failing computer -- though rebooting it seems to have righted it for the ...
7 comments:
Wednesday, May 25, 2016

London Calling Preview

›
ON Thursday and Friday this week Oxford Nanopore will be holding their second annual London Calling meeting.  I successfully defended my sch...
7 comments:
Tuesday, May 24, 2016

Inconstant lines

›
If you order chemicals, then the supplier provides a certificate of analysis, which shows the amounts of impurities or their limit of detect...
Sunday, May 22, 2016

Sickle Cell Anemia: An underprioritized disease?

›
The Sunday Boston Globe today had a front page piece by STAT's Sharon Begley that asks some challenging questions about prioritization ...
Friday, May 20, 2016

Kendall Square Tech/Biotech/Biopharma Needs to Get Vocal About Transit!

›
Earlier this week, the current big Boston-area mass construction transit project, known as GLX, went through a near-death experience.  The p...
Wednesday, May 18, 2016

Exploring Critiques of Siddhartha Mukerjee's The Gene, An Intimate History

›
My finely tuned skills in the art of procrastination KOed my plans to see Siddhartha Mukerjee's talk tonight at a local bookstore (appar...
1 comment:
Friday, May 06, 2016

Around the World in Amino Acids

›
This post is pure whimsy, growing out of killing time on a train ride. The not-so-serious question: what is the geography of amino acids?  I...
1 comment:
Thursday, April 28, 2016

Genia Publishes Platform Progress

›
Nanopore sequencing developer Genia published in PNAS last week a study demonstrating the basics of their current approach to sequencing.  ...
2 comments:
Tuesday, April 05, 2016

Protein Homeostasis: Has it Hit The Classrooms Yet?

›
I wrote a piece earlier this year suggesting that introductory Biology textbooks should emphasize protein complexes more .  My basis for ass...
1 comment:
Sunday, April 03, 2016

Mosquito Genomes: Chance for Long-Range Companies to Shine

›
Friday's New York Times carried a front-page illustration of the current status of the Aedes aegyptii genome, accompanying an Amy Harm...
2 comments:
Thursday, March 31, 2016

Reflections on And The Band Played On

›
Fellow blogger, colleague and science history buff Ash pointed out to me recently that Randy Shilt 's And The Band Played On  for Kindl...
Wednesday, March 30, 2016

Who Wants To Write A Review Article?

›
Yes, this is a solicitation.  I'm on the Editorial Board of the journal Briefings in Bioinformatics ,.  I'm looking for authors who ...
3 comments:
Tuesday, March 29, 2016

At the Edge of The Cloud

›
I've used cloud computing at Amazon Web Services (AWS) off-and-on now for over five years.  The cloud has all sorts of handy advantages ...
13 comments:
Friday, March 25, 2016

Selective sequencing: A Programming Opportunity!

›
I ask a bit of indulgence from my regular readership for this piece, as I am going to explain a number of things in depth that probably will...
6 comments:
Friday, March 18, 2016

PacBio's big splash

›
[18 March 2016 -- my original inclusion of the Pac Bio marketing image 6 years ago was claimed to be a DCMA violation -- I've simply rem...
1 comment:
Monday, March 14, 2016

A Mosquito ExAC?

›
Okay, there's a scheme for a crazy big genomics project has bitten me, infecting my brain.  It's definitely not something I'm in...
3 comments:
Wednesday, March 09, 2016

Oxford's Riposte To Illumina Trade Action

›
Along with the " No thanks, I've already got one " online session, the other big Oxford Nanopore news is the public release of...
6 comments:
Tuesday, March 08, 2016

Oxford's "No thanks, I've already got one"

›
Oxford Nanopore today hosted a Google hangout titled " No thanks, I've already got one ".  Only this morning did it occur to...
8 comments:
Thursday, February 25, 2016

Digging into the Illumina Lawsuit vs. Oxford Nanopore

›
Illumina's and University of Washington's filing of a patent lawsuit and related trade complaint against Oxford Nanopore made big ...
9 comments:
Wednesday, February 24, 2016

Amplification-free, library-free sequencing? NanoString wants to be It

›
Perhaps the most unusual new technology to be unveiled at AGBT16 is NanoString's new approach to sequencing, which is in very early st...
‹
›
Home
View web version

About Me

My photo
Keith Robison
Dr. Robison spent 10 years at Millennium Pharmaceuticals working with various genomics & proteomics technologies & working on multiple teams attempting to apply these throughout the drug discovery process. He spent 2 years at Codon Devices working on a variety of protein & metabolic engineering projects as well as monitoring a high-throughput gene synthesis facility. After a brief bit of consulting, he rejoined the cancer drug discovery field at Infinity Pharmaceuticals in May 2009. In September 2011 he joined Warp Drive Bio, a startup applying genomics to natural product drug discovery. In February 2019 he joined Ginkgo Bioworks, a synthetic biology company. Other recurring characters in this blog are his late loyal Shih Tzu Amanda, his current Shih Poo Lily and his now adult son alias TNG (The Next Generation). Dr. Robison can be reached via his Gmail account, keith.e.robison@gmail.com You can also follow him on Twitter as @OmicsOmicsBlog.
View my complete profile
Powered by Blogger.